Featured Active Pharmaceutical Ingredients & Peptides
Explore our premium therapeutic peptides, incretin analogues, and specialized custom chemical entities engineered for research and commercial scale-up.
High-Quality Eptifibatide CAS 188627-80-7 - High-Quality China Suppliers and Factory for Platelet Aggregation Inhibition Manufacturer, Service
Request Quote
High-Quality Semax Peptide CAS 80714-61-0 - Premier China Suppliers & Factory for CNS Health Solutions Manufacturer, Pricelist
Request Quote
High-Quality Thymosin β4 Acetate (TB500) CAS 77591-33-4 - China Suppliers & Factory for Enhanced Wound Healing and Healing Potentials Manufacturers, Service
Request Quote
High-Quality Tirzepatide CAS 2023788-19-2: Leading China Suppliers & Factory for Advanced Weight Management Solutions Manufacturer, Quotes
Request Quote
High-Quality Mazdutide (CAS 2259884-03-0) - Weight Loss Dual GCG/GLP-1 Agonist from China Suppliers & Factory Manufacturer, Quotes
Request Quote
High-Quality Survodutide CAS: 2805997-46-8 from China Suppliers - Quality Products from Trusted Factory Manufacturer, Quotes
Request Quote
Custom Vasopressin (CAS NO: 50-57-- Trusted China Suppliers & Factory for Antidiuretic Hormone (ADH) Manufacturer, Manufacturers
Request QuoteAtrial Natriuretic Peptide (ANP): Molecular Architecture, Synthesis Dynamics & Therapeutic Scope
A comprehensive analytical overview of custom ANP synthesis, conformational stabilization, and industrial-scale peptide manufacturing paradigms.
Atrial Natriuretic Peptide (ANP), also recognized historically as atriopeptin or ANF (atrial natriuretic factor), is a 28-amino-acid cyclic peptide hormone synthesized, stored, and secreted primarily by cardiac myocytes within the atria of the heart in response to atrial stretch, hypervolemia, and elevated intravascular pressure. As a foundational regulator of systemic cardiovascular homeostasis, renal hemodynamics, and extracellular fluid volume, ANP executes potent natriuretic, diuretic, and vasodilatory cascades while functioning as a primary endogenous antagonist to the Renin-Angiotensin-Aldosterone System (RAAS).
From a chemical synthesis and industrial CDMO standpoint, ANP presents an intricate peptide architecture requiring rigorous process controls. The canonical human ANP sequence comprises 28 amino acid residues: H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH. The structural integrity and biological potency of ANP depend strictly upon the formation of an intramolecular disulfide bridge between Cysteine-7 (Cys7) and Cysteine-23 (Cys23). This 17-amino-acid disulfide loop creates a highly conserved spatial conformation required for high-affinity binding to Natriuretic Peptide Receptor-A (NPR-A / NPRA), triggering intracellular accumulation of cyclic guanosine monophosphate (cGMP).
Structural & Biochemical Features of Custom ANP Peptide
Synthesis requires precise regioselective oxidation to yield the native Cys7–Cys23 disulfide linkage while preventing intermolecular dimerization, methionine oxidation at Met12, and racemization of arginine or phenylalanine residues during long-chain assembly.
Exact Mass & Sequence Integrity
Molecular Weight: 3080.44 Da. Monoisotopic mass confirmation via High-Resolution LC-MS/MS with comprehensive peptide mapping to ensure zero sequence deletion contaminants.
Controlled Oxidation State
Orthogonal protection of cysteine residues (e.g., Cys(Trt) vs Cys(Acm)) enables regioselective liquid-phase or solid-phase oxidation, eliminating misfolded structural isomers.
Endotoxin-Controlled Grade
Depyrogenated, sterile-filtered, sub-0.01 EU/mg preparation specifically developed for pre-clinical cardiovascular modeling, cell receptor assays, and formulation stability testing.
Global ANP Sourcing Demands & Industrial Supply Chain Bottlenecks
Addressing the technical risk factors, yield loss mechanisms, and vendor qualification challenges faced by global pharmaceutical buyers.
Primary Sourcing Bottlenecks
Procurement directors and biopharmaceutical formulation teams frequently encounter significant roadblocks during the vendor selection process for custom ANP quotes:
- Methionine Oxidation Sensitivity: Met12 is highly susceptible to conversion into methionine sulfoxide [Met(O)] during resin cleavage, TFA deprotection, or storage, leading to product degradation.
- Disulfide Misfolding & Dimer Formation: Non-optimized oxidative cyclization leads to parallel/antiparallel dimeric artifacts and insoluble aggregates, lowering final chromatographic yields.
- Poly-Arg Sequence Deletions: The presence of five arginine (Arg) residues (Arg3, Arg4, Arg11, Arg14, Arg27) causes severe steric aggregation during automated synthesis if coupling cycles are unoptimized.
- Regulatory & Batch Traceability Gaps: Non-cGMP standard suppliers often lack comprehensive impurity profiling (impure deletion peptides, beta-alanine isomers, enantiomeric purity data).
Enterprise Solutions by Thinheal CDMO
Thinheal solves these industrial hurdles through specialized chemical strategies and proprietary process analytical technology (PAT):
- Scavenger Cocktail Optimization: Implementation of specialized TFA/EDT/thioanisole/anisole cleavage matrices that completely suppress Met12 oxidation during global deprotection.
- Dilute High-Yield Air/Iodine Cyclization: Industrial scale cyclization in high-dilution aqueous-organic solvent mixtures ensuring >95% conversion to monomeric cyclic ANP.
- Double-Coupling Microwave-Assisted SPPS: Aggressive microwave heat-assisted coupling protocols for all Arg and hydrophobic residues, preventing incomplete chain assembly.
- Full Analytical Transparency: Every custom ANP batch is accompanied by UPLC-MS, 2D NMR, amino acid analysis (AAA), residual solvent analysis (GC-HS), and heavy metal validation.
Macro-Industry Solutions: Technical Synthesis Roadmap for ANP Peptides
From milligram custom synthesis to multi-kilogram commercial production: Comparing synthesis routes and purification workflows.
To successfully commercialize ANP analogues, therapeutic candidates, and diagnostic standards, CDMO platforms must evaluate solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), and hybrid fragment condensation routes based on batch volume requirements, cost of goods sold (COGS), and yield constraints.
| Synthesis Paradigm | Target Scale | Chemical Strategy | Chromatographic Yield | Industrial Suitability |
|---|---|---|---|---|
| Fmoc/tBu Solid-Phase (SPPS) | 1g - 500g | Microwave-assisted automated SPPS on CTC or Wang resin; orthogonal Cys protection. | 45% - 65% | Ideal for rapid custom quotes, R&D trials, and preliminary clinical batches. |
| Hybrid Fragment Condensation | 500g - 10kg | Liquid-phase coupling of protected 7-mer and 21-mer peptide fragments; post-coupling cyclization. | 60% - 75% | Highly cost-effective for medium-to-large scale API production. |
| Recombinant / Enzymatic Ligation | > 10kg | Biosynthetic precursor expression in E. coli followed by enzymatic C-terminal cleavage & folding. | 70% - 85% | Extreme volume scale-up; requires specialized expression host qualification. |
Detailed Process Flow: Thinheal's Industrial ANP Production Protocol
The manufacturing process for high-purity Atrial Natriuretic Peptide follows a strict quality-by-design (QbD) protocol:
- Step 1: Solid-Phase Backbone Assembly: Automated Fmoc-SPPS is performed utilizing high-swelling resin substrates. Pseudoproline dipeptides (e.g., Fmoc-Ser(tBu)-Thr(psi Me,Me pro)-OH) are introduced at critical points to suppress beta-sheet aggregation along the 28-amino-acid backbone.
- Step 2: Regioselective Disulfide Formation: Upon completion of the peptide sequence, oxidation is achieved either on-resin using iodine in DMF or off-resin in aqueous solution at pH 7.8 under controlled dissolved oxygen and redox-buffer conditions (glutathione/GSSG).
- Step 3: Multi-Stage Preparative RP-HPLC Purification: The crude cyclic ANP mixture undergoes dynamic axial compression (DAC) preparatory reverse-phase HPLC using TEAP/acetonitrile and TFA/acetonitrile mobile phases, isolating the target peak from closely eluting deletion peptides.
- Step 4: Lyophilization & Salt Conversion: Purified fraction pools undergo trifluoroacetate (TFA) to acetate or hydrochloride ion exchange followed by industrial freeze-drying under Class 100 cleanroom environments.
Technical Roadmap: Long-Acting Derivatives & Chemical Modifications
Innovations in half-life extension, peptide stabilization, and non-canonical amino acid substitution.
PEGylation & Lipidation
Native ANP exhibits a short in vivo plasma half-life (< 5 minutes) due to rapid degradation by Neutral Endopeptidase 24.11 (neprilysin) and clearance via NPR-C. Custom modification services include site-specific N-terminal or C-terminal PEGylation (20kDa-40kDa) and fatty diacid conjugation (e.g., C18/C20 diacids via gamma-Glu spacers) to dramatically extend half-life.
Non-Natural Amino Acid Substitutions
Incorporation of D-amino acids, N-methylated residues, or beta-amino acids at cleavage-vulnerable peptide bonds (such as the Cys7-Phe8 or Arg14-Ile15 bonds) enhances proteolytic resistance against neprilysin while preserving NPR-A agonist activation efficiency.
Cyclic Stapled ANP Constructs
Hydrocarbon stapling technology replacing traditional disulfide bonds with olefinic or lactam bridges. Stapled ANP analogues exhibit heightened conformational rigidity, resistance to reducing environments, and superior thermal stability.
Global Commercial Landscape: Industrial & Clinical Applications of ANP
Where custom synthesis ANP peptides are driving breakthrough innovations across pharmaceutical industries.
Cardiovascular & Renal Therapeutics
Atrial Natriuretic Peptide and its synthetic derivatives (e.g., Carperitide, Anaritide) serve as vital active pharmaceutical ingredients for acute heart failure, decompensated chronic heart failure, and acute kidney injury (AKI). By inducing arterial vasodilation, increasing glomerular filtration rate (GFR), and reducing cardiac preload and afterload, ANP therapeutics offer major clinical value over conventional diuretics.
Diagnostic Assay Reference Standards
In clinical diagnostics, accurate quantification of ANP and N-terminal pro-ANP (NT-proANP) levels is essential for diagnosing early-stage heart failure, hypertensive crises, and fluid overload conditions. High-purity custom ANP peptides serve as primary analytical standards for ELISA, Radioimmunoassay (RIA), and Mass Spectrometry diagnostic assay kits globally.
Metabolic & Adipose Tissue Research
Recent physiological discoveries highlight ANP's potent role in metabolic regulation. ANP triggers lipid mobilization in human adipocytes via cGMP-dependent protein kinase I (cGKI) activation, inducing browning of white adipose tissue and upregulating uncoupling protein-1 (UCP1). Consequently, custom ANP analogues are in high demand for obesity, NASH/MASH, and metabolic syndrome research.
Cosmetic & Anti-Aging Skincare Formulations
Emerging research indicates natriuretic peptide receptor expression within human skin fibroblasts and keratinocytes. Tailored short-chain ANP-mimetic peptides are increasingly integrated into premium anti-aging skincare products to promote microcirculation, enhance collagen synthesis, and restore cellular hydration dynamics.
Localization Support, Quality Assurance & Regulatory Dossier Delivery
Ensuring compliance with international regulatory frameworks for seamless customs clearance and IND/DMF filings.
cGMP & ISO Certification
All commercial peptide API manufacturing operations adhere to ICH Q7 guidelines, supported by ISO 9001:2015 and ISO 13485 quality systems.
Regulatory DMF & IND Support
Comprehensive Drug Master File (DMF) documentation, including full structural confirmation (FTIR, NMR, Mass), stability data (ICH Q1A), and impurity limits.
Cold-Chain Global Logistics
Validated packaging under temperature-controlled conditions (-20°C or dry ice) with real-time data loggers ensuring chemical stability during transport.
Batch COA & Testing
Individual batch certificates listing RP-HPLC purity, ESI-MS molecular weight verification, Karl Fischer water content, and endotoxin levels.
Custom ANP Peptide Quotes & Service Technical FAQ
Expert answers to critical procurement, chemical synthesis, and technical sourcing inquiries.
What purity grades are available for custom ANP peptide orders?
Thinheal supplies custom Atrial Natriuretic Peptide at multiple certified purity levels depending on application: Research Grade (>90% or >95%), Analytical/Diagnostic Grade (>98%), and cGMP Bio-Pharmaceutical Grade (>99% with <0.01 EU/mg endotoxin control). All purity measurements are confirmed by RP-HPLC analysis.
How does Thinheal ensure correct disulfide bond formation (Cys7-Cys23)?
We utilize orthogonal cysteine protection chemistries during SPPS synthesis (e.g., Cys(Trt) vs Cys(Acm)) combined with controlled, high-dilution air oxidation or iodine oxidation parameters. This prevents misfolded cyclic isomers and dimeric artifacts, ensuring 100% proper monomeric Cys7-Cys23 disulfide bridge formation.
Can you manufacture custom ANP sequences with chemical modifications?
Yes. Our CDMO capabilities accommodate N-terminal/C-terminal modifications (acetylation, amidation, biotinylation, fluorescent tagging like FITC/FAM), PEGylation (2k to 40k), fatty acid lipidation (C14-C20), isotope labeling (13C, 15N), and incorporation of non-standard D-amino acids or stapled bridges.
What is the standard turnaround time for a custom ANP quote and production?
Quotations are typically provided within 12 to 24 hours upon receipt of sequence specs. Standard laboratory synthesis and analytical testing require 2 to 3 weeks. Express synthesis protocols can deliver research-grade batches in as fast as 10 to 12 business days.
What batch documentation and CoA details are provided with delivery?
Every shipment includes a comprehensive Certificate of Analysis (CoA) containing High-Performance Liquid Chromatography (RP-HPLC) chromatograms, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra, Solubility Reports, Loss on Drying/Water Content, and Peptide Content determination.
How should custom ANP peptides be stored to maintain long-term stability?
Lyophilized ANP peptide powder should be stored at -20°C or -80°C away from light and moisture. Upon reconstitution in sterile, desalted aqueous buffers, aliquots should be frozen immediately to avoid repeated freeze-thaw cycles and prevent Met12 oxidation.
More High-Purity Custom Peptides & API Solutions
Explore our complete range of specialized metabolic, central nervous system, and anti-aging peptides ready for worldwide commercial dispatch.
Custom Retatrutide CAS 2381089-83-2: Leading China Suppliers & Factory for Obesity and T2DM Treatment Solutions Manufacturer, Quotes
Request Quote
High-Quality Vasopressin CAS 50-57-7 - China Suppliers & Factory for Antidiuretic Hormone, Water Regulation and Blood Pressure Management Manufacturer, Manufacturers
Request Quote
High-Quality Semax Peptide CAS 80714-61-0 - Top China Suppliers & Factory for Enhanced CNS Effects Manufacturers, Pricelist
Request Quote
Custom Thymalin CAS 63958-90-7 - China Suppliers Factory for Immune System Support & Polypeptide Therapy Manufacturers, Service
Request Quote